Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
US-9,382,257 Substituted pyrrolo[2,3-b]pyrazines as serine/threonine kinase inhibitors
Compounds having the formula I wherein R.sup.1 and R.sup.2 are as defined herein are inhibitors of ERK kinase. Also disclosed are compositions and methods for...
US-9,382,256 Formulation of Syk inhibitors
Disclosed are pharmaceutical compositions comprising a compound having the formula: ##STR00001## or a pharmaceutically acceptable salt thereof, or a hydrate...
US-9,382,255 Substituted pyrrolopyrimidinylamino-benzothiazolones as MKNK kinase inhibitors
The present invention relates to substituted pyrrolopyrimidinylamino-benzothiazolone compounds of general formula I as described and defined herein, to methods...
US-9,382,254 Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
The present invention discloses compounds according to Formula I: ##STR00001## wherein R.sup.1, R.sup.2, R.sup.3, L, and the subscript m are as defined herein....
US-9,382,253 Metal complexes
The present invention relates to metal complexes which contain polymerizable groups and to the polymers obtained using these metal complexes and to electronic...
US-9,382,252 Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and...
The present invention relates to the use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders...
US-9,382,251 Compositions comprising folic acid derivatives, their preparations and methods of use
Described herein are methods for making folic acid derivatives, intermediates, pharmaceutical compositions and uses thereof.
US-9,382,250 Method for producing complex crystal and method for screening complex crystal
The present invention relates to a method for producing a complex crystal composed of two or more different compounds, comprising crystallizing the two or more...
US-9,382,249 Antitumor aza-benzo [f] azulen derivative, method for preparing same, and use thereof
The present invention relates to the field of pharmaceutical chemistry, and particularly to an aza-benzo[f]azulen derivative (I) and an antitumor effect...
US-9,382,248 Mnk inhibitors and methods related thereto
The present invention relates to compounds according to Formula (I): ##STR00001## or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof,...
US-9,382,247 Salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders
The present invention discloses salts of a Compound 1: ##STR00001## useful in the prophylaxis and/or treatment of inflammatory conditions, autoimmune diseases,...
US-9,382,246 Inhibitors of Bruton's tyrosine kinase
Disclosed herein are reversible and irreversible inhibitors of Bruton's tyrosine kinase (Btk). Also disclosed are pharmaceutical compositions that include the...
US-9,382,245 Compounds and methods for treating HIV infections
The present invention is directed to novel nanomolar and picomolar inhibitors of HIV reverse transcriptase, pharmaceutical compositions therefrom and methods...
US-9,382,244 7-azaindole-2,7-naphthyridine derivative for the treatment of tumours
The compound 4-(2-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)-2,7-naphthyridin-1-ylamine and pharmaceutically usable salts and/or tautomers thereof. The use of this ...
US-9,382,243 Azabenzimidazole tetrahydropyran derivatives
Novel compounds of the structural formula (I) are activators of AMP-protein kinase and may be useful in the treatment, prevention and suppression of diseases...
US-9,382,242 Preparation and use of compounds as protease inhibitors
Disclosed are compounds of the formula I ##STR00001## or a stereoisomer, tautomer, or pharmaceutically acceptable salt or solvate thereof, wherein Q is a...
US-9,382,241 Aminoquinazoline and pyridopyrimidine derivatives
The invention provides novel compounds having the general formula: ##STR00001## wherein A, R.sup.1, R.sup.2 and R.sup.3 are as defined herein, compositions...
US-9,382,240 Crystalline salts of a potent HCV inhibitor
This invention relates to novel tris(hydroxymethyl)aminomethane, choline and N-methyl-D-glucamine salt forms of the following Compound (1) and methods for the...
US-9,382,239 Inhibitors of c-Jun-N-terminal kinase (JNK)
The present invention provides novel compounds according to Formula (I): where Ring A, Ring B, X, L.sub.1, L.sub.2, R.sup.A, R.sup.C, R.sup.D, R.sup.E, m, n,...
US-9,382,238 Pyridine derivatives as rearranged during transfection (RET) kinase inhibitors
This invention relates to novel compounds which are inhibitors of the Rearranged during Transfection (RET) kinase, to pharmaceutical compositions containing...
US-9,382,237 3,5-diaminopyrazole kinase inhibitors
Provided herein are 3,5-diaminopyrazoles, for example, compounds of Formula IA, that are useful for modulating regulated-in-COPD kinase activity, and...
US-9,382,236 P2X4 receptor antagonist
The present invention relates to a diazepine derivative represented by the following general formula (I) (in the formula, R.sup.1 and R.sup.2 represent hydrogen...
US-9,382,235 Unsolvated crystalline form 1 of N-[5-(3, ...
The present invention relates to a process for the preparation of N-[5-(3,5-difluoro-benzyl)-1H ...
US-9,382,234 Enhancer of Zeste Homolog 2 inhibitors
This invention relates to novel compounds according to Formula (I) which are inhibitors of Enhancer of Zeste Homolog 2 (EZH2), to pharmaceutical compositions...
US-9,382,233 Forms of vilazodone and processes for the preparation thereof
Vilazodone hydrochloride benzyl alcohol solvates are provided as well as processes for the preparation thereof.
US-9,382,232 Quinoline and cinnoline derivatives and their applications
The present invention relates to a series of quinoline and cinnoline derivatives of general formula I, pharmaceutically acceptable salts, hydrates, solvates or...
US-9,382,231 Bipyrazole derivatives as JAK inhibitors
The present invention provides compounds of Formula I: ##STR00001## or pharmaceutically acceptable salts thereof, as well as their compositions and methods of...
US-9,382,230 Methods and compositions for modulating Ire1, SRC and ABL activity
Disclosed herein are, inter alia, compositions for modulating Ire1, Src, or Abl, methods for identifying modulating activity in test compounds, and methods for...
US-9,382,229 Compounds and methods of use thereof for treating neurodegenerative disorders
Compounds, compositions, kits and methods for treating conditions related to neurodegeneration or ocular disease, are disclosed.
US-9,382,228 N-acyl-N'-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities
Described are compounds of Formula I ##STR00001## which find utility in the treatment of cancer, autoimmune diseases and metabolic bone disorders through...
US-9,382,227 Phenylethanolamine-based NMDA receptor antagonists
Described herein are enhanced N-methyl-D-aspartate (NMDA) receptor antagonists, pharmaceutical compositions thereof, and their methods of use and treatment,...
US-9,382,226 Aldosterone synthase inhibitors
The invention involves compounds of structural Formula (I) and the pharmaceutically acceptable salts thereof. The compounds of the invention are effective at...
US-9,382,225 Reduction of C--O bonds by catalytic transfer hydrogenolysis
The present invention relates to a method of reducing a C--O bond to the corresponding C--H bond in a substrate which could be a benzylic alcohol, allylic...
US-9,382,224 7-acyloxychromen-4-one derivatives and the use thereof as self-tanning substances
The present invention relates to chromen-4-one derivatives of the formula (I), to the use thereof as self-tanning substance or for increasing melanin synthesis,...
US-9,382,223 Process for preparation of dronedarone by oxidation of a hydroxyl group
The invention relates to a novel process for the preparation of dronedarone (I) and pharmaceutically acceptable salts thereof (formula I), which comprises...
US-9,382,222 Benzyl sulfonamide derivatives as RORc modulators
Compounds of the formula Ia or Ib: ##STR00001## or pharmaceutically acceptable salts thereof, wherein m, n, p, q, r, A, X.sup.1, X.sup.2, X.sup.3, X.sup.4, Y,...
US-9,382,221 Compounds, compositions, and methods for treating alzheimer's disease
Novel methods and compounds for treating Alzheimer's Disease are provided. In one aspect, the invention provides methods for treating Alzheimer's Disease by...
US-9,382,220 Methods of synthesis and/or purification of diaminophenothiazinium compounds
Described are methods of synthesis and/or purification of certain 3,7-diamino-phenothiazin-5-ium compounds (referred to herein as "diaminophenothiazinium...
US-9,382,219 Cyclic protein tyrosine kinase inhibitors
Novel cyclic compounds and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of protein...
US-9,382,218 N-heteroaryl substituted aniline derivatives as HCV-antivirals
The present invention discloses compounds of Formula (I): wherein the variables in Formula I are defined as described herein. Also disclosed are pharmaceutical...
US-9,382,217 Modulators of sphingosine phosphate receptors
Compounds that activate a sphingosine-1-phosphate receptor of the subtype 1 are provided. Certain compounds selectively activate the receptor subtype 1 in...
US-9,382,216 Substituted morpholines as modulators for the calcium sensing receptor
Compounds of Formula (I) along with processes for their preparation that are useful for treating, managing and/or lessening the diseases, disorders, syndromes...
US-9,382,215 Therapeutic methods and agents for treating myotonic dystrophy
The invention provides compounds, compositions and methods for treating myotonic dystrophy. The compounds can selectively bind to CUG repeats in RNA, or to CTG...
US-9,382,214 Processes for the preparation of uracil derivatives
The present invention relates to processes and intermediates for preparing Gonadotropin-Releasing Hormone (GnRH) receptor antagonists of structure (VI); and...
US-9,382,213 Heterocyclic and cyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase
Compounds of Formula I and Formula IA are inhibitors of dihydrofolate reductase and are suitable for use in compositions and methods for dihydrofolate reductase...
US-9,382,212 Preparation of and formulation comprising a MEK inhibitor
The present invention relates to processes for preparing 6-(4-bromo-2-fluorophenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-car- boxylic acid...
US-9,382,211 Stabilized multi-functional antioxidant compounds and methods of use
Disclosed are novel stable compounds having anti-oxidant properties and methods of using the compounds for the treatment of diseases or injuries associated with...
US-9,382,210 Articles and methods comprising persistent carbenes and related compositions
Articles and methods comprising persistent carbenes are provided, as well as related compositions. In some embodiments, a persistent carbene may be associated...
US-9,382,209 Polymorphic forms of ivabradine hydrochloride
Stable crystalline Form II and stable crystalline Form III of ivabradine hydrochloride and processes for their preparation are disclosed.
US-9,382,208 Negative allosteric modulators of metabotropic glutamate receptor 2
Described are negative allosteric modulators of metabotropic glutamate receptor 2 (mGlu.sub.2), pharmaceutical compositions including the compounds, and methods...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.